Literature DB >> 3102018

Calcitonin secretion in streak gonad syndrome (Turner's syndrome).

J Zseli, P Bosze, F Szalay, J Szucs, C Horvath, E Kollin, M Szathmari, J Laszlo, I Hollo.   

Abstract

Osteoporosis in one of the most common complications of streak gonad syndrome (SGS), however, its pathogenesis is still unclear. To test whether SGS is associated with calcitonin (CT) deficiency, 11 affected individuals and 8 age-matched healthy women were studied. Calcium, 3.6 mg/kg b.w. as a 10% solution of calcium chloride, was given intravenously for 3 minutes. Serum levels of CT and calcium were measured before and at 5, 30, 60, and 120 minutes after the injection. There was a statistically significant rise in serum calcium levels both in the control subjects and patients with SGS, with significantly lower levels prior to and at 30, 60, and 120 minutes following calcium load in the control group. The CT rise following calcium load was also significant at 5, 30, and 60 minutes in the controls and at 5 and 30 minutes in patients with SGS, with a significantly lower baseline and 30, 60, and 120 minutes levels in the latter group. Maximum levels of calcium and CT occurred 5 minutes after the calcium load and were statistically indistinguishable. There were no significant differences in either the calcium or the CT incremental changes between the two groups. These findings are consistent with decreased basal (and 30-120 minute) CT levels in SGS and suggest that CT deficiency may be involved in the development of osteoporosis in patients with SGS. The possible causal relationship of estrogen deficiency to the reduced CT levels in SGS is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3102018     DOI: 10.1007/bf02555193

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  17 in total

1.  Effect of intravenous calcium load on plasma calcitonin level in postmenopausal osteoporosis.

Authors:  J Zséli; C Horváth; J Szücs; I Holló
Journal:  Lancet       Date:  1982-05-01       Impact factor: 79.321

2.  Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis?

Authors:  H M Taggart; C H Chesnut; J L Ivey; D J Baylink; K Sisom; M B Huber; B A Roos
Journal:  Lancet       Date:  1982-02-27       Impact factor: 79.321

3.  Decreased calcitonin reserve in accelerated postmenopausal osteoporosis.

Authors:  J Zséli; J Szücs; K Steczek; M Szathmári; E Kollin; C Horváth; M Guoth; I Holló
Journal:  Horm Metab Res       Date:  1985-12       Impact factor: 2.936

4.  Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens.

Authors:  J C Stevenson; G Abeyasekera; C J Hillyard; K G Phang; I MacIntyre; S Campbell; P T Townsend; O Young; M I Whitehead
Journal:  Lancet       Date:  1981-03-28       Impact factor: 79.321

5.  Evaluation of the role of calcitonin deficiency in ovariectomy-induced osteopenia.

Authors:  D N Kalu; R R Hardin
Journal:  Life Sci       Date:  1984-06-11       Impact factor: 5.037

6.  Effect of sex hormones on bone in primary osteoporosis.

Authors:  B L Riggs; J Jowsey; P J Kelly; J D Jones; F T Maher
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

7.  Comparison of human calcitonin secretion after a 1-minute calcium infusion in young normal and in elderly subjects.

Authors:  S Morimoto; T Onishi; Y Okada; K Tanaka; M Tsuji; Y Kumahara
Journal:  Endocrinol Jpn       Date:  1979-04

8.  Relative deficiency of plasma-calcitonin in normal women.

Authors:  C J Hillyard; J C Stevenson; I MacIntyre
Journal:  Lancet       Date:  1978-05-06       Impact factor: 79.321

9.  Calcium-regulating hormones during the menstrual cycle.

Authors:  R M Pitkin; W A Reynolds; G A Williams; G K Hargis
Journal:  J Clin Endocrinol Metab       Date:  1978-09       Impact factor: 5.958

10.  Deficiency of calcitonin in age related osteoporoses.

Authors:  G Milhaud; M Benezech-Lefevre; M S Moukhtar
Journal:  Biomedicine       Date:  1978-11
View more
  3 in total

1.  Serum bone Gla protein in streak gonad syndrome.

Authors:  J Zséli; P Bösze; P Lakatos; P Vargha; G Tarján; E Kollin; C Horváth; J László; I Holló
Journal:  Calcif Tissue Int       Date:  1991-06       Impact factor: 4.333

2.  Skeletal size and bone mineral content in Turner's syndrome: relation to karyotype, estrogen treatment, physical fitness, and bone turnover.

Authors:  R W Naeraa; K Brixen; R M Hansen; C Hasling; L Mosekilde; J H Andresen; P Charles; J Nielsen
Journal:  Calcif Tissue Int       Date:  1991-08       Impact factor: 4.333

Review 3.  Osteoporosis from the point of view of the clinical endocrinologist.

Authors:  J Szũcs
Journal:  Agents Actions       Date:  1994-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.